170 related articles for article (PubMed ID: 2349682)
41. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR
Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310
[No Abstract] [Full Text] [Related]
42. Fractional excretion of sodium during pulses of methylprednisolone for treatment of acute rejection in heart and kidney transplants.
Lloveras JJ; Tran Van T; Magues JP; Bernadet P; Durand D; Suc JM
Transplant Proc; 1990 Aug; 22(4):1384-5. PubMed ID: 2389337
[No Abstract] [Full Text] [Related]
43. Comment to the presentation of clinical correlations with drug measurements.
Land W
Transplant Proc; 1990 Jun; 22(3):1292. PubMed ID: 2349689
[No Abstract] [Full Text] [Related]
44. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Yoshida T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531
[No Abstract] [Full Text] [Related]
45. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
[No Abstract] [Full Text] [Related]
46. A rapid and specific assay for the du Pont aca discrete clinical analyzer, performed directly on whole blood.
Hansen JB; Lau HP; Janes CJ; Lehane DP; Miller WK
Transplant Proc; 1990 Jun; 22(3):1189-92. PubMed ID: 2190380
[No Abstract] [Full Text] [Related]
47. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts.
Collier DS; Calne RY; De Curtins M; Thiru S; White DJ; Jamieson NV; Thick M; Barroso E
Transplant Proc; 1987 Feb; 19(1 Pt 2):1279-80. PubMed ID: 3274318
[No Abstract] [Full Text] [Related]
48. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
[No Abstract] [Full Text] [Related]
49. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
[No Abstract] [Full Text] [Related]
50. Potential for CsA-Neoral in organ transplantation.
Levy G; Grant D
Transplant Proc; 1994 Oct; 26(5):2932-4. PubMed ID: 7940926
[No Abstract] [Full Text] [Related]
51. Impact of cyclosporine on organ transplantation.
Margreiter R
Transplant Proc; 1991 Aug; 23(4):2180-2. PubMed ID: 1871835
[No Abstract] [Full Text] [Related]
52. Cyclosporine in pediatric liver transplantation: is there a therapeutic blood level that abrogates rejection?
Margarit C; Martinez Ibáñez V; Potau N; Iglesias J; Boix Ochoa J
Transplant Proc; 1988 Jun; 20(3 Suppl 3):369-74. PubMed ID: 3291270
[No Abstract] [Full Text] [Related]
53. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
[No Abstract] [Full Text] [Related]
54. Therapeutic cyclosporine monitoring: comparison of radioimmunoassay and high-performance liquid chromatography methods in organ transplant recipients.
Hirvisalo EL; Kivistö KT; Neuvonen PJ
Ther Drug Monit; 1990 Jul; 12(4):353-8. PubMed ID: 2396309
[TBL] [Abstract][Full Text] [Related]
55. Covariables in cyclosporine immunosuppression.
Grevel J; Napoli KL; Kahan BD
Transplant Proc; 1990 Jun; 22(3):1113-5. PubMed ID: 2349671
[No Abstract] [Full Text] [Related]
56. Consensus statements on the optimal use of cyclosporine in pediatric patients.
Brodehl J
Transplant Proc; 1994 Oct; 26(5):2759-62. PubMed ID: 7940869
[No Abstract] [Full Text] [Related]
57. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
[No Abstract] [Full Text] [Related]
58. Ciclosporin in renal transplantation.
Land W; Castro LA; White DJ; Hillebrand G; Hammer C; Klare B; Fornara P
Prog Allergy; 1986; 38():293-328. PubMed ID: 3523493
[No Abstract] [Full Text] [Related]
59. Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation.
Belitsky P; MacDonald A; Cohen A; VGivner M; Sketris I
Transplant Proc; 1988 Jun; 20(3 Suppl 3):78-81. PubMed ID: 3291314
[No Abstract] [Full Text] [Related]
60. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
Macris MP; Frazier OH; Van Buren CT; Duncan JM
Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
